Effect of Bulleyaconitine A(BLA) on Adjuvant Arthritis Rats

Long Li,Zhao Jin-xia,Jia Ru-lin,Liu Yan-ying,Han Lei,Li Zhan-guo
DOI: https://doi.org/10.3969/j.issn.1672-3384.2013.01.005
2013-01-01
Abstract:Objective:To evaluate the effect of bulleyaconitine A(BLA) on adjuvant arthritis rats.Method:AA Wistar rats were induced by Freund's complete adjuvant,Beginning from the onset of AA,AA Wistar rats were randomly assigned to bulleyaconitine A(at a dose of 50μg/kg(n=12),or 100μg/kg(n=12)),or Aqua pro injection(at a dose of 100μL,n=12),once daily,respectively,for seven days.Increased percentage of body weight,change of circumference of ancle,and scores of arthritic flexion pain test were evaluated.The levels of TNF-α,INF-γ,PGE2 and β-EP were measured with the use of ELISA.Result:A 100μg/kg of BLA can significantly reduce the circumference of arthritic ankle starting from the 2nd day(p<0.05),and the same result occurred at 50μg/kg of BLA from the 3rd day(p<0.05).BLA produced significant analgesia at a dose of 100μg/kg(p<0.05).The levels of TNF-α and PGE2 increased in 100μg/kg BLA treated rats(p<0.01).The levels of TNF-α in rats treated with 50μg/kg BLA decreased significantly as compared with Aqua pro injection group(p<0.01),and there was no difference between 50μg/kg group and 100μg/kg group.Conclusion:BLA can improve the inflammation of AA rats,which was correlated with its ability of reducing the TNF-α and PGE2 levels in serum.BLA can also reduce inflammatory pain by reducing the level of PGE2 and increasing the level of β-EP in serum.
What problem does this paper attempt to address?